List view / Grid view
22 April 2016 | By Victoria White, Digital Content Producer
Researchers have developed a unique mouse model that will allow scientists to better study the genetic origins and potential treatments for ALS...
22 April 2016 | By SMi Group
SMI Reports (12.04.2016): MedImmune Senior Director for R&D to present keynote address on MED10382 at the 3rd Peptides Conference in London...
21 April 2016 | By Victoria White, Digital Content Producer
Researchers have mapped out the pathways of a set of neurons responsible for the kinds of motor impairments found in patients with Parkinson's disease...
21 April 2016 | By Victoria White, Digital Content Producer
ARGX-115 targets the novel immuno-oncology target GARP, a protein believed to contribute to immunosuppressive effects of T-cells...
20 April 2016 | By Victoria White, Digital Content Producer
Emergent BioSolutions' ES425 molecule is being developed as a potential therapeutic for triple-negative breast cancer (TNBC)...
20 April 2016 | By Victoria White, Digital Content Producer
Enterome Bioscience has raised €14.5 million in a Series C financing round that it will use to advance the development of its lead drug candidate EB 8018...
19 April 2016 | By Victoria White, Digital Content Producer
Evidence is mounting that even mild chronic cold stress in lab mice is skewing results in studies of cancer, inflammation, and more...
19 April 2016 | By Victoria White, Digital Content Producer
Johnson Matthey and Domainex have announced a collaboration to provide integrated small molecule pharmaceutical discovery and development services...
19 April 2016 | By Victoria White, Digital Content Producer
Results of a new study could help researchers develop more effective combination therapies and breathe new life into forgotten pancreatic cancer drugs...
19 April 2016 | By Victoria White, Digital Content Producer
New preclinical data show the combination of lenvatinib and everolimus yield greater antitumour activity than either agent alone in kidney cancer...
19 April 2016 | By Victoria White, Digital Content Producer
Enterome has signed a license agreement with Vertex to research, develop and commercialise novel small molecule FimH antagonists...
18 April 2016 | By Victoria White, Digital Content Producer
A biodegradable nanoparticle, developed by researchers at Northwestern Medicine, offers an innovative way to halt asthma...
18 April 2016 | By Victoria White, Digital Content Producer
IPI-549 is an orally administered immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma)...
18 April 2016 | By Victoria White, Digital Content Producer
SEL24 is a dual inhibitor of PIM and FLT3 kinases. It is the first molecule with this mechanism of action to progress to such stage of development...
18 April 2016 | By Victoria White, Digital Content Producer
Heptares and Kymab are to colllaborate to discover, develop and commercialise novel antibody therapeutics targeting a number of GPCRs...
